Stonepine Capital Management, LLC Yumanity Therapeutics, Inc. Transaction History

Stonepine Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.81 - $10.48 $1.35 Million - $5.05 Million	-481,692 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$8.3 - $12.04 $329,783 - $478,385	39,733 Added 8.99%	481,692 $4.97 Million
Q2 2021 Aug 16, 2021	BUY	$11.27 - $19.64 $1.2 Million - $2.09 Million	106,214 Added 31.64%	441,959 $5.15 Million
Q1 2021 May 14, 2021	BUY	$16.69 - $22.52 $3.79 Million - $5.11 Million	226,898 Added 208.46%	335,745 $6.08 Million
Q4 2020 Feb 12, 2021	BUY	$16.67 - $25.4 $1.81 Million - $2.76 Million	108,847 New	108,847 $1.85 Million

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.